Exploring Antifibrotic Therapy in Patients with Autoimmune-Associated Interstitial Lung Disease PILOTforPulmonary: 2019 Fall Conference Coverage 3 min Listen "Exploring Antifibrotic Therapy in Patients with Autoimmune-Associated Interstitial Lung Disease" Reproducir Descargar episodio More episodes of the podcast PILOTforPulmonary: 2019 Fall Conference Coverage Current Perspective on Antifibrotic Therapy for Patients with IPF Nintedanib in Progressive Fibrosing Interstitial Lung Diseases (The INBUILD Trial) Goals of Care Across the Disease Continuum in IPF Emerging Diagnostic Approaches to Patients with ILD Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease Considerations for Geriatric ILD Patients Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease Inhaled NO in Patients at Risk for Pulmonary Hypertension Associated with Pulmonary Fibrosis Clinical Pearls from New Orleans 2019 The IPF Cell Atlas Ver todos los episodios Share Facebook Twitter LinkedIn
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
In God we trust In God we trust